Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
46.30
+0.15 (0.33%)
Oct 31, 2025, 1:21 PM CST
0.33%
Market Cap4.02B
Revenue (ttm)4.48B
Net Income (ttm)-322.97M
Shares Out86.75M
EPS (ttm)-3.72
PE Ration/a
Forward PEn/a
Dividend1.00 (2.16%)
Ex-Dividend DateJul 7, 2025
Volume33,859
Average Volume51,537
Open46.45
Previous Close46.15
Day's Range46.20 - 47.00
52-Week Range40.05 - 60.70
Beta0.22
RSI25.24
Earnings DateNov 11, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.